Reply to 'Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers'

被引:2
|
作者
Bakalos, Georgios [1 ,2 ]
Schreitmueller, Thomas [3 ]
机构
[1] Hoffmann La Roche Ltd, Global Prod Dev Med Affairs, Basel, Switzerland
[2] Univ Thessaly, Sch Med, Dept Biomath, Larisa, Greece
[3] Hoffmann La Roche Ltd, Roche Pharma Tech Operat, Basel, Switzerland
关键词
D O I
10.1136/esmoopen-2017-000281
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [1] Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers
    Tabernero, Josep
    Vyas, Malvika
    Giuliani, Rosa
    Arnold, Dirk
    Cardoso, Fatima
    Casali, Paolo G.
    Cervantes, Andres
    Eggermont, Alexander M. M.
    Eniu, Alexandru
    Jassem, Jacek
    Pentheroudakis, George
    Peters, Solange
    Rauh, Stefan
    Zielinski, Christoph C.
    Stahel, Rolf A.
    Voest, Emile
    Douillard, Jean-Yves
    McGregor, Keith
    Ciardiello, Fortunato
    [J]. ESMO OPEN, 2016, 1 (06)
  • [2] Knowledge and use of biosimilars in oncology: a survey by the European Society for Medical Oncology
    Giuliani, Rosa
    Tabernero, Josep
    Cardoso, Fatima
    McGregor, Keith Hanson
    Vyas, Malvika
    de Vries, Elisabeth G. E.
    [J]. ESMO OPEN, 2019, 4 (02)
  • [3] The off-label use of drugs in oncology: a position paper by the European Society for Medical Oncology (ESMO)
    Casali, P. G.
    [J]. ANNALS OF ONCOLOGY, 2007, 18 (12) : 1923 - 1925
  • [4] European Society for Medical Oncology (ESMO) position paper on supportive and palliative care
    Jordan, K.
    Aapro, M.
    Kaasa, S.
    Ripamonti, C. I.
    Scotte, F.
    Strasser, F.
    Young, A.
    Bruera, E.
    Herrstedt, J.
    Keefe, D.
    Laird, B.
    Walsh, D.
    Douillard, J. Y.
    Cervantes, A.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 (01) : 36 - 43
  • [5] Adolescents and young adults (AYA) with cancer: a position paper from the AYA Working Group of the European Society for Medical Oncology (ESMO) and the European Society for Paediatric Oncology (SIOPE)
    Ferrari, A.
    Stark, D.
    Peccatori, F. A.
    Fern, L.
    Laurence, V
    Gaspar, N.
    Bozovic-Spasojevic, I
    Smith, O.
    De Munter, J.
    Derwich, K.
    Hjorth, L.
    van der Graaf, W. T. A.
    Soanes, L.
    Jezdic, S.
    Blondeel, A.
    Bielack, S.
    Douillard, J-Y
    Mountzios, G.
    Saloustros, E.
    [J]. ESMO OPEN, 2021, 6 (02)
  • [6] SOCIETY FOR PEDIATRIC ONCOLOGY AND HEMATOLOGY - A POSITION PAPER
    WINKLER, K
    [J]. KLINISCHE PADIATRIE, 1995, 207 (04): : 133 - 135
  • [7] European Society for Medical Oncology 2020
    Rupert Bartsch
    [J]. memo - Magazine of European Medical Oncology, 2021, 14 : 130 - 131
  • [8] European Society for Medical Oncology 2020
    Bartsch, Rupert
    [J]. MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY, 2021, 14 (02) : 130 - 131
  • [9] European Society of Medical Oncology (ESMO)
    Kibble, A.
    [J]. DRUGS OF THE FUTURE, 2020, 45 (11) : 849 - 859
  • [10] American Society of Clinical Oncology Statement: Biosimilars in Oncology
    Lyman, Gary H.
    Balaban, Edward
    Diaz, Michael
    Ferris, Andrea
    Tsao, Anne
    Voest, Emile
    Zon, Robin
    Francisco, Michael
    Green, Sybil
    Sherwood, Shimere
    Harvey, R. Donald
    Schilsky, Richard L.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (12) : 1260 - +